NPI: 1982607115 · FAYETTEVILLE, NC 28301 · General Acute Care Hospital · NPI assigned 05/23/2005
Authorized official FISER, JOSEPH controls 20+ related entities in our dataset. Read more
| Authorized Official | FISER, JOSEPH (VP MANAGED CARE AND REVENUE CYCLE) |
| NPI Enumeration Date | 05/23/2005 |
Other providers sharing the same authorized official: FISER, JOSEPH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,223 | $376K |
| 2019 | 25,963 | $364K |
| 2020 | 7,929 | $176K |
| 2021 | 9,976 | $245K |
| 2022 | 15,724 | $441K |
| 2023 | 17,087 | $550K |
| 2024 | 16,108 | $553K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 17,880 | 15,384 | $680K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 12,583 | 10,802 | $369K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 1,461 | 973 | $338K |
| 87428 | 3,515 | 3,095 | $234K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5,465 | 4,712 | $200K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 6,026 | 5,017 | $166K |
| 81025 | 11,212 | 9,671 | $95K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 471 | 438 | $68K |
| 71046 | Radiologic examination, chest; 2 views | 1,370 | 1,164 | $67K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,558 | 3,186 | $57K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,191 | 1,027 | $51K |
| 41899 | Unlisted procedure, dentoalveolar structures | 31 | 26 | $32K |
| V2632 | Posterior chamber intraocular lens | 1,352 | 882 | $31K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,353 | 1,353 | $27K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,065 | 903 | $26K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,065 | 903 | $26K |
| 81002 | 7,152 | 5,976 | $25K | |
| 87070 | 2,324 | 2,041 | $22K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,400 | 1,337 | $18K |
| 84439 | 2,296 | 1,326 | $15K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 381 | 356 | $13K |
| J3490 | Unclassified drugs | 4,185 | 2,324 | $12K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,854 | 2,249 | $10K |
| 80053 | Comprehensive metabolic panel | 1,293 | 1,053 | $9K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 256 | 202 | $9K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 359 | 282 | $8K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 144 | 141 | $8K |
| 36415 | Collection of venous blood by venipuncture | 4,234 | 2,709 | $7K |
| 0353U | 269 | 244 | $6K | |
| 85027 | 1,113 | 911 | $5K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 54 | 30 | $5K |
| A9270 | Non-covered item or service | 1,622 | 655 | $5K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,033 | 826 | $5K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 393 | 327 | $5K |
| 87088 | 472 | 409 | $4K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 119 | 117 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 483 | 385 | $4K |
| 86376 | 355 | 218 | $4K | |
| 87210 | 873 | 748 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 69 | 61 | $4K |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 1,693 | 1,061 | $3K |
| 11043 | 24 | 13 | $3K | |
| J3370 | Injection, vancomycin hcl, 500 mg | 1,587 | 1,038 | $2K |
| 81003 | 627 | 550 | $2K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,407 | 867 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 19 | 17 | $2K |
| 73130 | 15 | 12 | $2K | |
| 77072 | 36 | 28 | $1K | |
| 84146 | 77 | 55 | $1K | |
| 73562 | 14 | 12 | $1K | |
| 80061 | Lipid panel | 130 | 68 | $1K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 116 | 97 | $855.32 |
| 83690 | 127 | 115 | $821.59 | |
| 86255 | 86 | 52 | $780.52 | |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 1,381 | 862 | $601.59 |
| 82043 | 151 | 79 | $569.59 | |
| 83516 | 67 | 39 | $556.92 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 19 | 17 | $518.66 |
| 82570 | 155 | 81 | $516.00 | |
| 87807 | 31 | 30 | $503.40 | |
| 82784 | 65 | 39 | $451.62 | |
| 84484 | 63 | 56 | $445.35 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 37 | 26 | $363.18 |
| 82670 | 18 | 12 | $356.04 | |
| 87077 | 59 | 37 | $349.20 | |
| 82947 | 290 | 167 | $332.61 | |
| 83001 | 18 | 13 | $301.08 | |
| 83002 | 18 | 13 | $300.04 | |
| 86800 | 25 | 14 | $277.48 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 48 | 40 | $249.26 |
| J2704 | Injection, propofol, 10 mg | 32 | 27 | $238.37 |
| 82550 | 44 | 42 | $236.95 | |
| 83519 | 19 | 12 | $202.08 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 47 | 39 | $186.35 |
| 82565 | 52 | 28 | $185.92 | |
| 87186 | 15 | 14 | $128.38 | |
| 82150 | 15 | 15 | $114.43 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 18 | 15 | $99.90 |
| 82552 | 18 | 13 | $72.07 | |
| 87205 | 16 | 13 | $47.79 |